Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.45 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 2/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378297 | 1.00 | SMN1; SMN2 (0.48) | SMN1; SMN2LMNAKEAP1NFE2L2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6988496 | 0.98 | SMN1; SMN2 (0.47) | SMN1; SMN2LMNAKEAP1NFE2L2ALDH1A1 | |
| SCHEMBL29608609 | 0.83 | HCAR2 (0.36) | SMN1; SMN2LMNAALDH1A1TP53HCAR2 | |
| SCHEMBL1160933 | 0.83 | HCAR2 (0.36) | SMN1; SMN2LMNAALDH1A1TP53HCAR2 | |
| SCHEMBL9684853 | 0.81 | ALDH1A1 (0.45) | SMN1; SMN2LMNAKEAP1NFE2L2ALDH1A1 | |
| SCHEMBL329752 | 0.81 | CA1 (0.48) | SMN1; SMN2LMNAKEAP1NFE2L2ALDH1A1 | |
| SCHEMBL4719997 | 0.81 | SMN1; SMN2 (0.47) | SMN1; SMN2LMNAKEAP1NFE2L2ALDH1A1 | |
| SCHEMBL4016084 | 0.81 | CASP1 (0.46) | LMNAALDH1A1CASP1KDM4EGAA | |
| SCHEMBL4971916 | 0.81 | MAPK1 (0.40) | SMN1; SMN2LMNAHCAR2HSD17B10HPGD | |
| SCHEMBL30370236 | 0.81 | CASP1 (0.46) | LMNAALDH1A1CASP1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9012553-A | — | — | None | — | — | JP | disclosed |
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4705298-A2 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | Moma Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4703364-A1 | QUINOLONE ANALOG AND USE THEREOF | Horizon Omics Biotech Limited (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-12559508-B2 | Semi-saturated bicyclic derivatives and related uses | MOMA THERAPEUTICS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4076460-B1 | 1,4-DIHYDRO-2H-SPIRO[ISOQUINOLINE-3,4'-PIPERIDINE DERIVATIVES AS PRMT5 INHIBITORS FOR THE TREATMENT OF CANCER | MERCK SHARP & DOHME LLC (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | LIEBER INST INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12441730-B2 | PRMT5 inhibitors | MERCK SHARP & DOHME LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250230171-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. | 2025-07-17 | — | — | US | disclosed |
| US-12234221-B2 | Pyridine carboxamide compounds for inhibiting NAV1.8 | LIEBER INSTITUTE, INC. (US) | 2025-02-25 | — | — | US | disclosed |
| EP-0634413-A1 | Herbicides | RHONE POULENC AGRICULTURE LTD. (GB) | 1995-01-18 | — | — | EP | disclosed |
| EP-0388994-B1 | Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds | ISHIHARA SANGYO KAISHA (JP) | 1994-10-05 | — | — | EP | disclosed |
| EP-0232067-B2 | Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds | ISHIHARA SANGYO KAISHA (JP) | 1994-03-16 | — | — | EP | disclosed |
| EP-0388994-A1 | Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1990-09-26 | — | — | EP | disclosed |
| US-RE32975-E | FUNGICIDES, BACTERICIDES, FEED ADDITIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | disclosed |
| EP-0232067-A2 | Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds | ISHIHARA SANGYO KAISHA LTD. (JP) | 1987-08-12 | — | — | EP | disclosed |
| EP-0092117-B1 | PROCESS FOR PRODUCING CHLORONICOTINIC ACID COMPOUNDS | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1987-07-15 | — | — | EP | disclosed |
| EP-0092117-A1 | Process for producing chloronicotinic acid compounds | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1983-10-26 | — | — | EP | disclosed |
| EP-0056144-A1 | Carboxylic acid derivatives, their preparation and use as pharmaceuticals | Dr. Karl Thomae GmbH (DE) | 1982-07-21 | — | — | EP | disclosed |
| US-4284629-A | ANIMAL GROWTH REGULATORS | BAYER AKTIENGESELLSCHAFT (DE) | 1981-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250230171-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | POLQ, POLB, POLK | SMN1; SMN2 1987/4885LMNA 757/4885KEAP1 4428/4885 |
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | POLA1, SUB1, CTDSP1 | SMN1; SMN2 836/4885LMNA 95/4885KEAP1 2890/4885 |
| US-12559508-B2 | Semi-saturated bicyclic derivatives and related uses | POLA1, CTDSP1, SUB1 | SMN1; SMN2 1518/4885LMNA 119/4885KEAP1 3121/4885 |
| US-12234221-B2 | Pyridine carboxamide compounds for inhibiting NAV1.8 | SCN8A, SCN1A, SCN2A | SMN1; SMN2 189/4885LMNA 1580/4885KEAP1 2893/4885 |
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | SCN8A, SCN1A, SCN1B | SMN1; SMN2 456/4885LMNA 916/4885KEAP1 2132/4885 |
| US-12441730-B2 | PRMT5 inhibitors | PRMT5, PRMT1, PRMT3 | SMN1; SMN2 349/4885LMNA 1841/4885KEAP1 443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.